These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 507788)

  • 1. LY127935, a novel oxa-beta-lactam: an in vitro comparison with other beta-lactam antibiotics.
    Wise R; Andrews JM; Bedford KA
    Antimicrob Agents Chemother; 1979 Sep; 16(3):341-5. PubMed ID: 507788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.
    Borobio MV; Aznar J; Jimenez R; Garcia F; Perea EJ
    Antimicrob Agents Chemother; 1980 Feb; 17(2):129-31. PubMed ID: 6247966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of in vitro activity of GR 20263, a novel cephalosporin derivative, with activities of other beta-lactam compounds.
    Wise R; Andrews JM; Bedford KA
    Antimicrob Agents Chemother; 1980 May; 17(5):884-9. PubMed ID: 6772097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
    Hall WH; Opfer BJ; Gerding DN
    Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of LY127935.
    Barza M; Tally FP; Jacobus NV; Gorbach SL
    Antimicrob Agents Chemother; 1979 Sep; 16(3):287-92. PubMed ID: 507785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of LY127935, a new 1-oxa cephalosporin, against aerobic gram-negative bacilli.
    Delgado DG; Brau CJ; Cobbs CG; Dismukes WE
    Antimicrob Agents Chemother; 1979 Dec; 16(6):864-8. PubMed ID: 533267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
    Baumgärtner M; Dickgiesser N; Müller S; Wundt W
    Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of cefotetan, a new cephamycin derivative, compared with that of other beta-lactam compounds.
    Wise R; Andrews JM; Hancox J
    Antimicrob Agents Chemother; 1982 Mar; 21(3):486-91. PubMed ID: 6954875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LY-127935: a novel beta-lactam antibiotic with unusual antibacterial activity.
    Trager GM; White GW; Zimelis VM; Panwalker AP
    Antimicrob Agents Chemother; 1979 Sep; 16(3):297-300. PubMed ID: 315753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters.
    Verbist L
    Arzneimittelforschung; 1981; 31(6):982-6. PubMed ID: 6266430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity and beta-lactamase stability of a new penem, CGP 31608.
    Neu HC; Chin NX; Neu NM
    Antimicrob Agents Chemother; 1987 Apr; 31(4):558-69. PubMed ID: 3496845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
    Phillips I; Warren C; Shannon K; King A; Hanslo D
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():23-31. PubMed ID: 19802967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of the cefotaxime (HR756) desacetyl metabolite compared with those of cefotaxime and other cephalosporins.
    Wise R; Wills PJ; Andrews JM; Bedford KA
    Antimicrob Agents Chemother; 1980 Jan; 17(1):84-6. PubMed ID: 7352752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae.
    Verbist L; Verhaegen J
    Antimicrob Agents Chemother; 1980 May; 17(5):807-12. PubMed ID: 6994640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.
    Jones RN; Fuchs PC; Sommers HM; Gavan TL; Barry AL; Gerlach EH
    Antimicrob Agents Chemother; 1980 Apr; 17(4):750-6. PubMed ID: 6446880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antimicrobial activity of cefotaxime, a new cephalosporin.
    Masuyoshi S; Arai S; Miyamoto M; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Jul; 18(1):1-8. PubMed ID: 6251749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of LY127935.
    Fass RJ
    Antimicrob Agents Chemother; 1979 Oct; 16(4):503-9. PubMed ID: 518080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial activity of the cephamycin cefotetan: an in-vitro comparison with other beta-lactam antibiotics.
    Clarke AM; Zemcov SJ
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():67-72. PubMed ID: 6404881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin.
    Une T; Mitsuhashi S
    Arzneimittelforschung; 1977; 27(1):89-93. PubMed ID: 576821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs.
    Fass RJ
    Arch Intern Med; 1980 Jun; 140(6):763-8. PubMed ID: 7387270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.